NEWS AND PUBLICATIONS
News
12/01/2009
Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration
10-06-2009
Galenea Awarded RC1 Challenge Grant to Develop Predictive In Vivo Models of Cognition
10/06/2008
Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration
05/21/2007
Galenea Corp. Appoints Mark Benjamin as Chief Executive Officer
04/07/2006
Galenea To Focus On Development Of CNS Drugs
02/16/2005
Galenea Corp. Signs Collaboration and License Agreement with Otsuka Pharmaceutical Co., Ltd.
Publications
Cottrell, JR, Li, B, and Gerber, DJ. Calcineurin A gamma is expressed in the brain and forms a functional phosphatase. Program No. 588.24. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for Neuroscience, 2006. Online.
Gogos, JA and Gerber, DJ (2006) Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends in Pharmacological Sciences, 27(4):226-233.
Miyakawa, T et al. (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. PNAS, 100(15):8987-92.
Gerber, DJ et al. (2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. PNAS, 100(15):8993-8.
Zeng, H et al. (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell, 107(5):617-629.